A Randomized, Open Label, Rater Blind, Flexible Dose Multi-Center Study Comparing The Efficacy And Safety Of Intramuscular Ziprasidone With Haloperidol For Three Days In Patients With Agitation Of Schizophrenia.

Trial Profile

A Randomized, Open Label, Rater Blind, Flexible Dose Multi-Center Study Comparing The Efficacy And Safety Of Intramuscular Ziprasidone With Haloperidol For Three Days In Patients With Agitation Of Schizophrenia.

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Jul 2015

At a glance

  • Drugs Ziprasidone (Primary) ; Haloperidol
  • Indications Agitation; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Feb 2013 Primary endpoint 'Brief-Psychiatric-Rating-Scale' has been met.
    • 06 Jun 2010 Results have been presented at the 27th International Congress of Collegium Internationale Neuro Psychopharmacologicum.
    • 13 Oct 2009 Actual patient number (376) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top